As of April 16, 2025, MeiraGTx (MGTX) has a market cap of $0.43 billion USD. According to our data, MeiraGTx is ranked No.6131 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.43 B |
-9.71%
|
Dec 31, 2024 | $0.48 B |
-13.25%
|
Dec 29, 2023 | $0.55 B |
7.67%
|
Dec 30, 2022 | $0.51 B |
-72.54%
|
Dec 31, 2021 | $1.86 B |
56.80%
|
Dec 31, 2020 | $1.18 B |
-24.38%
|
Dec 31, 2019 | $1.56 B |
107.68%
|
Dec 31, 2018 | $0.75 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$67.19 M |
-0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.18 B |
-0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.52 B |
0.000 M
|
![]() Netherlands
|
![]() Generation Bio
GBIO
|
$24.65 M |
0.000 M
|
![]() USA
|
![]() 4D Molecular Therapeutics
FDMT
|
$0.14 B |
0.000 M
|
![]() USA
|
Market Cap | = | MGTX Stock Price | * | MGTX Shares Outstanding |
= | $5.45 | * | 78.85 M | |
= | $0.43 B |